Navigation Links
Rosetta Genomics Announces Commercial Availability of Its Third MicroRNA-Based Diagnostic Test: miRview(TM) meso
Date:12/29/2008

REHOVOT, Israel, JERSEY CITY, New Jersey and PHILADELPHIA, Pennsylvania, December 29 /PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (NASDQ: ROSG), the leading developer of microRNA-based molecular diagnostics, announced today the introduction of its third diagnostic test, miRview(TM) meso. The test is now commercially available through Rosetta Genomics CLIA-certified lab in Philadelphia.

To order the test, physicians may contact 1-888-522-7971, or visit the company's website http://www.rosettagenomics.com.

"I am very excited to finally see a molecularly-based test that can objectively differentiate mesothelioma from several types of carcinomas in the lung with such high level of accuracy" noted Harvey Pass, MD, Division Chief for Thoracic Surgery and Thoracic Oncology at the New York University Langone Medical Center. "Ruling out Mesothelioma from lung cancer for individuals that were exposed to asbestos can be difficult and challenging. I am sure that this test will become an important tool for both oncologists and pathologists in obtaining the right diagnosis in these patients."

Malignant pleural mesothelioma is directly linked to exposure to asbestos particles, as well as to various heavy metals. Rescue workers, shipyard workers, and miners are at increased risk of developing mesothelioma. Currently, there is no single diagnostic test that is entirely conclusive for this differentiation. In addition, pathological diagnosis may suffer from significant inter-observer variability, and in the absence of a single specific and reliable test, mesothelioma can be difficult to identify from other cancers.

miRview(TM) meso differentiates mesothelioma, a cancer connected to asbestos exposure, from other carcinomas in the lung. Currently, there is no single diagnostic test that is entirely conclusive for this differe
'/>"/>

SOURCE Rosetta Genomics Ltd
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Rosetta Genomics to Webcast Panel Presentation at RBC Capital Markets 2008 Healthcare Conference
2. Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS
3. Rosetta Genomics Announces Conference Call and Webcast of Third Quarter Financial Results
4. /C O R R E C T I O N -- Rosetta Genomics Ltd/
5. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) Centennial Conference
6. Rosetta Genomics to Present at Oppenheimers 19th Annual Healthcare Conference
7. Credit Suisse Repurchases Auction Rate Securities (ARS) From Rosetta Genomics
8. Rosetta Genomics Leverages its MicroRNA Platform Technologies to Launch Plant Biotech Initiative
9. Rosetta Genomics to Present at the Upcoming EORTC-NCI-ASCO Annual Meeting on "Molecular Markers in Cancer"
10. Rosetta Genomics and the National Institute of Health (NIH) to Identify Potential MicroRNA Drug Targets for HIV
11. Rosetta Genomics Reports Second Quarter 2008 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... The New York investment bank KTA Capital,s cli...d an AU$6.7 mil convertible note private placement...lacement was arranged by KTA Capital as Neuren,s e... New York (PRWEB) November 23, 2009 ...pital, LLC ("KTA Capital") has announced...
(Date:11/24/2009)...HEIM,Ontario,Nov.24/PRNewswire-FirstCall/--DowAgro...ofHylandSeeds,adivisionofThompsonsLimitedofBlenhei...dDowAgroSciences,currentseedsbusinessasthecompanya... andDowAgroSciencesHerbicideTolerantTraitTechnolo...enearfuture. ,, "Thisacquisitionbringstogethert...
(Date:11/24/2009)...4/PRNewswire-FirstCall/--Sigma-AldrichCorporation(...enceonTuesday,December1stat1:45PMGMTinLondon,7:45A...dcastovertheInternetavailableat http://inve s t...bcast"icontoaccessthisfile. ,, AboutSigma-Ald...chnologycompany.Itschemicalandbiochemicalproductsa...
(Date:11/24/2009)...and,November24/PRNewswire-FirstCall/--deCODE,genet...allofits,"firstday"motionsbytheU.S.BankruptcyCourt...CODElastweekfiledavoluntarypetitionfor,reliefunder...nkruptcyCourt. , TheordersissuedbytheBankrupt...essduringtheChapter11proceedings.Inparticular,the,...
Breaking Biology Technology:KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3
...adison, Wis. -- Third Wave Technologies Inc. , a...of DNA and RNA analysis applications, is being sue...ges infringement of its hepatitis C virus patents.... a ruling against a California company over disput...nostic and therapeutic products, with a focus on i...
...om stem cell research to high-tech bicycles to an ...v. Tommy Thomspson, Wisconsin Technology Network r...ories they clicked on and read during the last thr... latest edition of Wisconsin Technology Review &s...hnology Network. , ,As in past reviews, we presen...
...adison, Wis. -- The WiCell Research Institute,s a...tigious four-year, $16 million federal contract to... is a sign of respect for the state,s pioneering a...h. , ,But, in the face of continued Wisconsin legi..., the path forward is anything but simple. , ,Emb...
Other Biology Technology:Third Wave sued by one firm; gets injunction against another 2WiCell to host new national stem cell bank 2WiCell to host new national stem cell bank 3WiCell to host new national stem cell bank 4
(Date:11/26/2009)...RSA (methicillin-resistant Staphylococcus Aureus ...ihilation as low-temperature plasma prototype devi... and unfailing bactericidal cocktails. , Two pro...ent disinfection of healthy skin (e.g. hands and f... can pose a lethal threat; and another to shoot ba...
(Date:11/25/2009)... Dr. Sarit Larisch, Head of the Cell Death Researc...nt of Biology, has been awarded the prestigious Jo...arch exploring the cause of brain cell damage in P...ch year to scientists in support of innovation and... officially conferred earlier this month at an eve...
(Date:11/24/2009)...or thousands of years it has been prescribed by tr...lments from headaches and stomach pain to fever an...ewcastle University have been able to scientifical...crenata otherwise known as Brazilian mint. , Te...e team led by researcher Graciela Rocha was able t...
Breaking Biology News(10 mins):Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Got a pain? -- Have a cup of Brazilian mint 2Agahozo Shalom Youth Village in Rwanda Dedicated 15 Years After Genocide to Provide Healing Community to African Orphans 48208 1Agahozo Shalom Youth Village in Rwanda Dedicated 15 Years After Genocide to Provide Healing Community to African Orphans 48208 2Agahozo Shalom Youth Village in Rwanda Dedicated 15 Years After Genocide to Provide Healing Community to African Orphans 48208 3Agahozo Shalom Youth Village in Rwanda Dedicated 15 Years After Genocide to Provide Healing Community to African Orphans 48208 4Dialysis Patient Citizens Endorses Kidney Community Campaign to Improve Survival Rates of First Year Dialysis Patients 48206 1Dialysis Patient Citizens Endorses Kidney Community Campaign to Improve Survival Rates of First Year Dialysis Patients 48206 2FYI From Human Genome Sciences 3A GlaxoSmithKline Study Shows GSKs Novel Diabetes Treatment Syncria 28R 29 28Albiglutide 29 Improves Glucose Control 4566 1FYI From Human Genome Sciences 3A GlaxoSmithKline Study Shows GSKs Novel Diabetes Treatment Syncria 28R 29 28Albiglutide 29 Improves Glucose Control 4566 2FYI From Human Genome Sciences 3A GlaxoSmithKline Study Shows GSKs Novel Diabetes Treatment Syncria 28R 29 28Albiglutide 29 Improves Glucose Control 4566 3
... COLD SPRING HARBOR, N.Y. Combining the specifi...th the versatility of lentiviral vectors gives res...gene function both in vivo and in vitro. This mon....cshprotocols.org/TOCs/toc8_08.dtl ) features a pa....edu/faculty/faculty_details.php?id=54 ) and colle...
...Basel, 4 August 2008. New data from studies presen...exico City have provided unprecedented insight int...sulfonate (EMS). The formation of the EMS impurit...f mesylate salts, which are contained in over 40 d...s were designed to determine the impact of elevate...
... ARTICLE #1 FOR IMMEDIATE RELEASE , New imaging ...h painting, Analytical Chemistry , European res... new imaging technique to reveal with unprecedente...it of a woman hidden underneath one of the fabled ...d provide new insights into the hidden details of ...
Other Biology News:Landmark studies assess risk of exposure to elevated levels of EMS confirm clear toxicity threshold 2American Chemical Society's Weekly PressPac -- July 30, 2008 2American Chemical Society's Weekly PressPac -- July 30, 2008 3American Chemical Society's Weekly PressPac -- July 30, 2008 4American Chemical Society's Weekly PressPac -- July 30, 2008 5American Chemical Society's Weekly PressPac -- July 30, 2008 6
MaxPlax Lambda Packaging Extract from EPICENTRE Biotechnologies
RNA Sample Buffer from Novagen
... 264. 7 cells were cultured in DMEM with 4 mM L-gl...rowth. In order to keep the antigens in their nat...The cells are arrayed on a 12-well (5 mm) adhesive...y treated to enhance cellular attachment and to mi...
...ontrol™ vector can be induced prior to DNA pur...vide the stability of single-copy BACs with the hi... vectors. The kits provide the linearized vector a...size screening system) necessary to create a 10X h...
Biology Products: